STUDYA small study (N=60) compared holding one preprocedure dose of a GLP-1 agonist (hold group) to not holding it (continuation group) in patients undergoing EGD with or without colonoscopy
These were calculated and analyzed using a light microscope with 400 times magnification
Lee MMY, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter NR, Badve SV, Pratley RE, Perkovic V, Buse JB, McGuire DK
ACA/individual-market plans generally exclude weight-loss Wegovy
Concurrent Medications or Supplements : Drugs or supplements that affect digestion, inflammation, or liver metabolism may impact absorption, efficacy, or tolerability of BPC-157
[PUBMED Abstract] Lennard CM, Patel A, Wilson J, et al.: Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer